Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis

被引：51

作者：

Ponsioen, Cyriel Y. ^{[1
]}

Lindor, Keith D. ^{[2
]}

Mehta, Ruby ^{[3
]}

Dimick-Santos, Lara ^{[3
]}

机构：

[1] Acad Med Ctr, Dept Gastroenterol Hepatol, POB 22700, NL-1100 DE Amsterdam, Netherlands

[2] Arizona State Univ, Coll Hlth Solut, Phoenix, AZ USA

[3] US FDA, Div Gastroenterol & Inborn Errors Prod, Silver Spring, MD USA

来源：

HEPATOLOGY | 2018年 / 68卷 / 03期

关键词：

DOSE URSODEOXYCHOLIC ACID; PRIMARY BILIARY-CIRRHOSIS; HISTOLOGIC SCORING SYSTEMS; NATURAL-HISTORY; ALKALINE-PHOSPHATASE; TRANSIENT ELASTOGRAPHY; PROGNOSTIC VALUE; ULCERATIVE-COLITIS; GRADING SYSTEM; LIVER-FUNCTION;

D O I：

10.1002/hep.29882

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Primary sclerosing cholangitis (PSC) is a rare and chronic liver disease for which there is no effective therapy. Interest has grown in developing treatments for this condition, with several agents proposed as potential therapies. However, there is a lack of clarity about how to measure clinical benefit in trials involving patients with this complex and rare disease. This article reviews regulatory information, the available literature on natural history, as well as potential candidate clinical and surrogate endpoints for PSC. (Hepatology 2018; 00:000-000).

引用

页码：1174 / 1188

页数：15

共 78 条

[1] Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline [J].

Aabakken, Lars ;

Karlsen, Tom H. .

JOURNAL OF HEPATOLOGY, 2017, 66 (06) :1265-1281

[2] Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis [J].

Al Mamari, Said ;

Djordjevic, Jelena ;

Halliday, John S. ;

Chapman, Roger W. .

JOURNAL OF HEPATOLOGY, 2013, 58 (02) :329-334

[3] Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis [J].

Alberts, Rudi ;

de Vries, Elisabeth M. G. ;

Goode, Elizabeth C. ;

Jiang, Xiaojun ;

Sampaziotis, Fotis ;

Rombouts, Krista ;

Bottcher, Katrin ;

Folseraas, Trine ;

Weismueller, Tobias J. ;

Mason, Andrew L. ;

Wang, Weiwei ;

Alexander, Graeme ;

Alvaro, Domenico ;

Bergquist, Annika ;

Bjorkstrom, Niklas K. ;

Beuers, Ulrich ;

Bjornsson, Einar ;

Boberg, Kirsten Muri ;

Bowlus, Christopher L. ;

Bragazzi, Maria C. ;

Carbone, Marco ;

Chazouilleres, Olivier ;

Cheung, Angela ;

Dalekos, Georgios ;

Eaton, John ;

Eksteen, Bertus ;

Ellinghaus, David ;

Farkkila, Martti ;

Festen, Eleonora A. M. ;

Floreani, Annarosa ;

Franceschet, Irene ;

Gotthardt, Daniel Nils ;

Hirschfield, Gideon M. ;

van Hoek, Bart ;

Holm, Kristian ;

Hohenester, Simon ;

Hov, Johannes Roksund ;

Imhann, Floris ;

Invernizzi, Pietro ;

Juran, Brian D. ;

Lenzen, Henrike ;

Lieb, Wolfgang ;

Liu, Jimmy Z. ;

Marschall, Hanns-Ulrich ;

Marzioni, Marco ;

Melum, Espen ;

Milkiewicz, Piotr ;

Mueller, Tobias ;

Pares, Albert ;

Rupp, Christian .

GUT, 2018, 67 (08) :1517-1524

[4] Time course of histological progression in primary sclerosing cholangitis [J].

Angulo, P ;

Larson, DR ;

Therneau, TM ;

LaRusso, NF ;

Batts, KP ;

Lindor, KD .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (11) :3310-3313

[5] EASL Clinical Practice Guidelines: Management of cholestatic liver diseases [J].

Beuers, Ulrich ;

Boberg, Kirsten M. ;

Chapman, Roger W. ;

Chazouilleres, Olivier ;

Invernizzi, Pietro ;

Jones, David E. J. ;

Lammert, Frank ;

Pares, Albert ;

Trauner, Michael .

JOURNAL OF HEPATOLOGY, 2009, 51 (02) :237-267

[6] Immunoglobulin G4 associated cholangitis:: Description of an emerging clinical entity based on review of the literature [J].

Bjornsson, Einar ;

Chari, Suresh T. ;

Smyrk, Thomas C. ;

Lindor, Keith .

HEPATOLOGY, 2007, 45 (06) :1547-1554

[7] Primary Sclerosing Cholangitis Associated with Elevated ImmunoglobulinG4: Clinical Characteristics and Response to Therapy [J].

Bjornsson, Einar ;

Chari, Suresh ;

Silveira, Marina ;

Gossard, Andrea ;

Takahashi, Naoki ;

Smyrk, Thomas ;

Lindor, Keith .

AMERICAN JOURNAL OF THERAPEUTICS, 2011, 18 (03) :198-205

[8] Population-Based Epidemiology, Malignancy Risk, and Outcome of Primary Sclerosing Cholangitis [J].

Boonstra, Kirsten ;

Weersma, Rinse K. ;

van Erpecum, Karel J. ;

Rauws, Erik A. ;

Spanier, B. W. Marcel ;

Poen, Alexander C. ;

van Nieuwkerk, Karin M. ;

Drenth, Joost P. ;

Witteman, Ben J. ;

Tuynman, Hans A. ;

Naber, Anton H. ;

Kingma, Paul J. ;

van Buuren, Henk R. ;

van Hoek, Bart ;

Vleggaar, Frank P. ;

van Geloven, Nan ;

Beuers, Ulrich ;

Ponsioen, Cyriel Y. .

HEPATOLOGY, 2013, 58 (06) :2045-2055

[9] Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease [J].

Boonstra, Kirsten ;

van Erpecum, Karel J. ;

van Nieuwkerk, Karin M. J. ;

Drenth, Joost P. H. ;

Poen, Alexander C. ;

Witteman, Ben J. M. ;

Tuynman, Hans A. R. E. ;

Beuers, Ulrich ;

Ponsioen, Cyriel Y. .

INFLAMMATORY BOWEL DISEASES, 2012, 18 (12) :2270-2276

[10] Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review [J].

Boonstra, Kirsten ;

Beuers, Ulrich ;

Ponsioen, Cyriel Y. .

JOURNAL OF HEPATOLOGY, 2012, 56 (05) :1181-1188

← 1 2 3 4 5 6 7 8 →